Cover ImageSALE
市場調查報告書

DNA定序的全球市場:2018年∼2022年

Global DNA Sequencing Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 601389
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
Back to Top
DNA定序的全球市場:2018年∼2022年 Global DNA Sequencing Market 2018-2022
出版日期: 2018年01月19日 內容資訊: 英文 120 Pages
簡介

關於DNA定序

DNA定序,是決定DNA鎖鏈中的4個核苷酸,也就是腺嘌呤、鳥嘌呤、胞嘧啶及胸腺嘧啶的正確依序的流程。

Technavio的分析師預測,從2018年到2022年之間,全球DNA定序市場將以20.93%的年複合成長率成長。

本報告提供全球DNA定序市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生命週期
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模與預測

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情形

第7章 市場區隔:各產品

  • 比較:各產品
  • 全球DNA定序市場:各類服務
  • 各設備,試劑,消耗品
  • 市場機會:各產品

第8章 客戶形勢

第9章 地區形勢

  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 容易DNA定序的生物資訊學工具
  • 臨床工作流程的採用的擴大
  • 慢性疾病的發病率的增加
  • 高精度司法鑑定用工具的需求高漲

第13章 業者情勢

  • 概要
  • 創造性破壞

第14章 供應商分析

  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Pacific Biosciences of California
  • Thermo Fisher Scientific
  • 其他有力的供應商

第15章 附錄

  • 簡稱清單
目錄
Product Code: IRTNTR20146

About DNA Sequencing

DNA sequencing is the process of determining the precise order of the four nucleotides, namely, adenine, guanine, cytosine, and thymine, in a strand of DNA.

Technavio's analysts forecast the global DNA sequencing market to grow at a CAGR of 20.93% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global DNA sequencing market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales DNA sequencing.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global DNA Sequencing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Pacific Biosciences of California
  • Thermo Fisher Scientific

Market driver

  • The all-inclusive cost structure of sequencing products
  • For a full, detailed list, view our report

Market challenge

  • Difficulties in clinical interpretations and inadequate reimbursements
  • For a full, detailed list, view our report

Market trend

  • Growth of the bioinformatics tools that make DNA sequencing easy
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Comparison by product
  • Global DNA sequencing market by services
  • Global DNA sequencing market by instruments, reagents, and consumables
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Regional comparison
  • DNA sequencing market in Americas
  • DNA sequencing market in EMEA
  • DNA sequencing market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Bioinformatics tools making DNA sequencing easy
  • Increasing adoption in clinical workflows
  • Increasing incidence of chronic diseases
  • Growing demand for high-accuracy forensic tools

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Pacific Biosciences of California
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global genomics market
  • Exhibit 02: Global genomics market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Cost of sequencing per genome in $ (2001-2015)
  • Exhibit 06: Market definition: Inclusions and exclusions checklist
  • Exhibit 07: Global DNA sequencing market
  • Exhibit 08: Validation techniques employed for market sizing 2017
  • Exhibit 09: Global DNA sequencing market 2017-2022 ($ billions)
  • Exhibit 10: Global DNA sequencing market: Year over year growth 2018-2022 (%)
  • Exhibit 11: Five forces analysis 2017
  • Exhibit 12: Five forces analysis 2022
  • Exhibit 13: Bargaining power of buyers
  • Exhibit 14: Bargaining power of suppliers
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition: Five forces 2017
  • Exhibit 18: Market condition: Five forces 2022
  • Exhibit 19: Global DNA sequencing market by product 2017-2022 (% share)
  • Exhibit 20: Comparison by product
  • Exhibit 21: Global DNA sequencing market by services 2017-2022 ($ billions)
  • Exhibit 22: Global DNA sequencing market by services: Year over year growth 2018-2022 (%)
  • Exhibit 23: Global DNA sequencing market by instruments, reagents, and consumables 2017-2022 ($ billions)
  • Exhibit 24: Global DNA sequencing market by instruments, reagents, and consumables: Year over year growth 2018-2022 (%)
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global DNA sequencing market by region 2017-2022 (% share)
  • Exhibit 28: Regional comparison
  • Exhibit 29: Cardiovascular statistics in US
  • Exhibit 30: DNA sequencing market in Americas: 2017-2022 ($ billions)
  • Exhibit 31: DNA sequencing market in Americas: Year over year growth 2018-2022 (%)
  • Exhibit 32: Top three countries in Americas
  • Exhibit 33: DNA sequencing market in EMEA: 2017-2022 ($ billions)
  • Exhibit 34: DNA sequencing market in EMEA: Year over year growth 2018-2022 (%)
  • Exhibit 35: Top three countries in EMEA
  • Exhibit 36: DNA sequencing market in APAC: 2017-2022 ($ billions)
  • Exhibit 37: DNA sequencing market in APAC: Year over year growth 2018-2022 (%)
  • Exhibit 38: Top three countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: Major M&A in global DNA sequencing market between 2007-2014
  • Exhibit 41: R&D funding for chronic diseases 2013-2016 ($ millions)
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: BGI: Overview
  • Exhibit 48: BGI: Business segments
  • Exhibit 49: BGI: Organizational developments
  • Exhibit 50: BGI: Geographic focus
  • Exhibit 51: BGI: Segment focus
  • Exhibit 52: BGI: Key offerings
  • Exhibit 53: F. Hoffmann-La Roche: Overview
  • Exhibit 54: F. Hoffmann-La Roche: Business segments
  • Exhibit 55: F. Hoffmann-La Roche: Organizational developments
  • Exhibit 56: F. Hoffmann-La Roche: Geographic focus
  • Exhibit 57: F. Hoffmann-La Roche: Segment focus
  • Exhibit 58: F. Hoffmann-La Roche: Key offerings
  • Exhibit 59: Illumina: Overview
  • Exhibit 60: Illumina: Business segments
  • Exhibit 61: Illumina: Organizational developments
  • Exhibit 62: Illumina: Geographic focus
  • Exhibit 63: Illumina: Segment focus
  • Exhibit 64: Illumina: Key offerings
  • Exhibit 65: Pacific Biosciences of California: Overview
  • Exhibit 66: Pacific Biosciences of California: Business segments
  • Exhibit 67: Pacific Biosciences of California: Organizational developments
  • Exhibit 68: Pacific Biosciences of California: Geographic focus
  • Exhibit 69: Pacific Biosciences of California: Segment focus
  • Exhibit 70: Pacific Biosciences of California: Key offerings
  • Exhibit 71: Thermo Fisher Scientific: Overview
  • Exhibit 72: Thermo Fisher Scientific: Business segments
  • Exhibit 73: Thermo Fisher Scientific: Organizational developments
  • Exhibit 74: Thermo Fisher Scientific: Geographic focus
  • Exhibit 75: Thermo Fisher Scientific: Segment focus
  • Exhibit 76: Thermo Fisher Scientific: Key offerings
Back to Top